Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (21-30 of 522) with videos related to

Pageof 53
Sort By:
The American Journal of the Medical Sciences|August 16, 2006
Statins, fracture risk, and bone remodeling: What is true?Manfredi Rizzo, Giovam Battista Rini
Current Pharmaceutical Design|November 15, 2011
There is more to predicting vascular disease than just established risk factorsManfredi Rizzo, D P Mikhailidis
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 12, 2022
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk ReductionAli A Rizvi, Manfredi Rizzo
Clinical Endocrinology|September 21, 2011
Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular riskManfredi Rizzo, Dimitri P Mikhailidis
Current Pharmaceutical Design|March 23, 2011
New lipid modulating drugs: the role of microsomal transport protein inhibitorsManfredi Rizzo, Anthony S Wierzbicki
Medicina (Kaunas, Lithuania)|October 26, 2024
Age-Related Changes in Insulin Resistance and Muscle Mass: Clinical Implications in Obese Older AdultsAli A Rizvi, Manfredi Rizzo
Frontiers in Clinical Diabetes and Healthcare|January 24, 2025
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risksIoannis Ilias, Lina Zabuliene, Manfredi Rizzo
Endocrine, Metabolic & Immune Disorders Drug Targets|October 14, 2022
Potassium Iodide in Nuclear Accidents: Give it Timely, Swiftly and JudiciouslyIoannis Ilias, Manfredi Rizzo, Georgios Meristoudis
International Journal of Cardiology|April 19, 2022
Treatment of diabetes and heart failure: Facts and hopesManfredi Rizzo, Domenico Cianflone, Francesco Maranta
Journal of Diabetes and Its Complications|September 19, 2024
Emerging treatment strategies for polycystic ovary syndrome women with obesity: Focus on glucagon-like peptide-1 receptor agonistsMojca Jensterle, Manfredi Rizzo, Andrej Janez
Pageof 53

Showing results (21-30 of 522) with videos related to

Sort By:
Pageof 53
The American Journal of the Medical Sciences|August 16, 2006
Statins, fracture risk, and bone remodeling: What is true?Manfredi Rizzo, Giovam Battista Rini
Current Pharmaceutical Design|November 15, 2011
There is more to predicting vascular disease than just established risk factorsManfredi Rizzo, D P Mikhailidis
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 12, 2022
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk ReductionAli A Rizvi, Manfredi Rizzo
Clinical Endocrinology|September 21, 2011
Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular riskManfredi Rizzo, Dimitri P Mikhailidis
Current Pharmaceutical Design|March 23, 2011
New lipid modulating drugs: the role of microsomal transport protein inhibitorsManfredi Rizzo, Anthony S Wierzbicki
Medicina (Kaunas, Lithuania)|October 26, 2024
Age-Related Changes in Insulin Resistance and Muscle Mass: Clinical Implications in Obese Older AdultsAli A Rizvi, Manfredi Rizzo
Frontiers in Clinical Diabetes and Healthcare|January 24, 2025
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risksIoannis Ilias, Lina Zabuliene, Manfredi Rizzo
Endocrine, Metabolic & Immune Disorders Drug Targets|October 14, 2022
Potassium Iodide in Nuclear Accidents: Give it Timely, Swiftly and JudiciouslyIoannis Ilias, Manfredi Rizzo, Georgios Meristoudis
International Journal of Cardiology|April 19, 2022
Treatment of diabetes and heart failure: Facts and hopesManfredi Rizzo, Domenico Cianflone, Francesco Maranta
Journal of Diabetes and Its Complications|September 19, 2024
Emerging treatment strategies for polycystic ovary syndrome women with obesity: Focus on glucagon-like peptide-1 receptor agonistsMojca Jensterle, Manfredi Rizzo, Andrej Janez
Pageof 53